Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Feb 18, 2011


GE Healthcare said this week that Life Sciences CEO and President Peter Ehrenheim will retire this year and will be replaced by Kieran Murphy, who currently is head of Global Commercial Operations, Life Sciences.

Murphy will step into job in April, and after a period of transition, Ehrenheim will retire at the end of July. Ehrenheim was a mechanical engineer with Pharmacia, which was acquired by Amersham in 1997, which in turn was acquired by GE. Murphy was CEO of Whatman, which was acquired by GE Healthcare in 2008. He also has worked at Janssen Pharmaceutical, at Vericore, and at Novartis.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.